Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020

Udgivet den 29-04-2020  |  kl. 13:15  |  

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the Company), a global, high-growth diagnostics company, today announced that it plans to release first quarter 2020 financial results before the open of the market on Tuesday, May 5, 2020.  Dr. Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief Financial Officer, will host a conference call to review the Company's financial results at 8:00 a.m. Eastern Time the same day.  The call will be concurrently webcast.

To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers or +1 (484) 365-2897 for international callers and reference confirmation code 8473556, approximately 15 minutes prior to start time.  To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at www.oxfordimmunotec.com.  The replay will be available on the Company's website for approximately 60 days.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, high-growth diagnostics company.  We bring energy and invention to a world in need of diagnostic truth.  Our leading product, the T-SPOT®.TB test, is used for diagnosing infection with Tuberculosis, the world's largest cause of death from infectious disease.  The T-SPOT.TB test has been approved for sale in over 60 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China.  The Company is headquartered near Oxford, U.K. and in Marlborough, MA.  Additional information can be found at www.oxfordimmunotec.com.

T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.

CONTACTS:

For Media and Investor Inquiries:
Matt McLaughlin
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
mtmclaughlin@oxfordimmunotec.com

\Hugin

Udgivet af: NPinvestordk

Mest læste lige nu

Nestlé sælger isforretning i USA: Vil skabe global leder i industrien
Aktier/tendens: Novo styrer mod kursfald i ventet negativ åbning
Aktier/tendens: Ørsteds gigantiske nedskrivninger ventes i fokus
Aktier/middag: Novo blandt højdespringerne i grønt C25 efter stor rentesænkning i USA
Aktier/tendens: Plusser i vente efter amerikansk rentereduktion
 

Seneste nyheder

11:39 Aktier/middag: Novo blandt højdespringerne i grønt C25 efter stor rentesænkning i USA
11:23 Apple har udsigt til advarsel fra EU for tætlukket styresystem
11:19 Rater på containerfragt falder igen - ni uger med fald på stribe
10:55 Norges Bank holder renten i ro og signalerer tidligst lempelser i 2025
10:15 H+H får genoptaget neutral dækning hos Danske Bank: Nedjustering ventes i tredje kvartal
09:42 Sampo: Perfekt timing for Topdanmark-opkøb efter strategiændringer
09:22 H+H får genoptaget neutral dækning hos Danske Bank
09:14 Aktier/åbning: Fuld grøn plade i C25 efter stor rentesænkning i USA
08:41 Obligationer/åbning: Let stigende rente trods amerikansk rentereduktion
08:31 Aktier/tendens: Plusser i vente efter amerikansk rentereduktion
08:13 Unicredit står klar som køber af Tysklands aktier i Commerzbank
08:09 Råvarer: Amerikansk rentenedsættelse giver ikke forventet boost til oliepriserne
07:58 Sampo om dansk børsnotering: Vi forpligter os til landet
07:11 Obligationer/tendens: Udsigt til let stigende rente trods amerikansk rentesænking
07:03 USA/lukning: Glæden over stor rentenedsættelse forsvandt - men er vendt tilbage
06:41 Asien: Stor amerikansk rentesænkning skaber grøn bølge med Tokyo som stjerneskud
06:36 Mærsks asiatiske konkurrenter viser positive takter torsdag
06:34 NTG køber tysk logistikselskab for 424 mio. kr.
06:33 USA's centralbank ser nu lavere inflation i 2024
06:33 Federal Reserve sænker sin ledende rente for første gang siden 2020